Gastrointestinal Biomarkers

Biomarker	Assay Purpose	Drug(s)	Diagnostic Test	Test ID
PD-L1	Gastric, GEJ, esophageal adenocarcinoma; ESCC	Pembrolizumab, Nivolumab	PDL1 Dako 22C3 PharmDX	PDL1UPPERGIMARCH2026
Claudin 18.2	Gastric or GEJ adenocarcinoma	Zolbetuximab	VENTANA CLDN18 (43-14A) RxDx	BMCLAUDIN18

Head & Neck Biomarkers

Biomarker	Assay Purpose	Drug(s)	Diagnostic Test	Test ID
PD-L1	Head and neck squamous cell carcinoma (HNSCC)	Pembrolizumab	PDL1 Dako 22C3 PharmDX	PDL1HNSCC22C3PEMBRO

Gyne Biomarkers

Biomarker	Assay Purpose	Drug(s)	Diagnostic Test	Test ID
PD-L1	Cervical cancer (SCC and Adenocarcinoma)	Pembrolizumab	PDL1 Dako 22C3 PharmDX	PDL1CERVIX
CEP17 SISH	Ploidy Analysis	N/A	VENTANA Inform Chromosome 17 probe	MOLARCEP17

Lung Biomarkers

Biomarker	Assay Purpose	Drug(s)	Diagnostic Test	Test ID
PD-L1	NSCLC stage II to IIIA	Atezolizumab	PDL1 SP263	PDL1NSCLCATEZOSP263

Breast Biomarkers

Biomarker	Assay Purpose	Drug(s)	Diagnostic Test	Test ID
PD-L1	Triple Negative Breast Cancer (TNBC)	Pembrolizumab	PDL1 Dako 22C3 PharmDX	PDL1TNBC22C3PEMBRO